(Q33863128)

29 July 2017

1 reference

title

A new concept in neurodegeneration: TNFalpha is a silencer of survival signals (English)

1 reference

29 July 2017

1 reference

3

Kelley KW

1 reference

29 July 2017

Venters HD

1

1 reference

PubMed ID

10717677

29 July 2017

Dantzer R

series ordinal

2

1 reference

29 July 2017

1 April 2000

1 reference

29 July 2017

Trends in Neurosciences

1 reference

29 July 2017

23

1 reference

29 July 2017

4

1 reference

29 July 2017

175-180

1 reference

RETRACTED: A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Adenosine: a mediator of interleukin-1beta-induced hippocampal synaptic inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

The P38 mitogen-activated protein kinase inhibitor SB203580 antagonizes the inhibitory effects of interleukin-1beta on long-term potentiation in the rat dentate gyrus in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Sickness behavior as a new target for drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

The changing landscape of ischaemic brain injury mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Innate and adaptive immune responses can be beneficial for CNS repair

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Cytokines and the nervous system. I: Expression and recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Platelet-activating factor receptor activation. An initiator step in HIV-1 neuropathogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Early neuronal expression of tumor necrosis factor-alpha after experimental brain injury contributes to neurological impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Neuroprotective effects of TNF binding protein in focal cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

HIV-1 Tat induces neuronal death via tumor necrosis factor-alpha and activation of non-N-methyl-D-aspartate receptors by a NFkappaB-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Neurotrophins protect cultured cerebellar granule neurons against the early phase of cell death by a two-component mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

The intracellular domain of p55 tumor necrosis factor receptor induces apoptosis which requires different caspases in naive and neuronal PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

An endogenous 55 kDa TNF receptor mediates cell death in a neural cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Exacerbation of damage and altered NF-kappaB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Mechanisms of tumor necrosis factor alpha action on neurodegeneration: interaction with insulin-like growth factor-1

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Prevention of constitutive TNF receptor 1 signaling by silencer of death domains

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Insulin-like growth factors regulate neuronal differentiation and survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Insulin-like growth factors as mediators of functional plasticity in the adult brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Quantitative autoradiographic localization of [125I]insulin-like growth factor I, [125I]insulin-like growth factor II, and [125I]insulin receptor binding sites in developing and adult rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

The role of neuronal growth factors in neurodegenerative disorders of the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Insulin-like growth factor I (IGF-I) is a critical trophic factor for developing cerebellar granule cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Regulation of neuronal survival by the serine-threonine protein kinase Akt

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Insulin-like growth factor I modulates c-Fos induction and astrocytosis in response to neurotoxic insult.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Plasma insulin-like growth factor I and IGF binding protein 3 levels in patients with acute cerebral ischemic injury

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Insulin-like growth factor-1 is a potent neuronal rescue agent after hypoxic-ischemic injury in fetal lambs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Displacement of insulin-like growth factors from their binding proteins as a potential treatment for stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Central administration of insulin-like growth factor-1 inhibits lipopolysaccharide-induced sickness behavior in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Tumor necrosis factor induces phosphorylation and translocation of BAD through a phosphatidylinositide-3-OH kinase-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Insulin-like growth factor I restores motor coordination in a rat model of cerebellar ataxia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

The genetic defect in ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Interleukin-1beta and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Antagonistic effects of interferon-gamma and interleukin-4 on fibroblast cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Interleukin-4 suppression of tumor necrosis factor alpha-stimulated E-selectin gene transcription is mediated by STAT6 antagonism of NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Transient exposure of human myoblasts to tumor necrosis factor-alpha inhibits serum and insulin-like growth factor-I stimulated protein synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphory

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Inhibition of protein phosphatases induces IGF-1-blocked neurotrophin-insensitive neuronal apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Etanercept: a review of its use in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

The role of cytokines in toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

Newcastle disease virus as an antineoplastic agent: induction of tumor necrosis factor-alpha and augmentation of its cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901533-7

7 January 2021

10.1016/S0166-2236(99)01533-7

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10717677